Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetic Interaction of NVP-1203-R1 and NVP-1203-R2 in Healthy Adults
NCT04181437Phase 1Completed
- Sponsor
- NVP Healthcare Co., Ltd.
- Start
- May 2020
- Primary completion
- May 2020
- Countries
- 1
01
Overview
Phase 1 trial, sponsored by NVP Healthcare Co., Ltd. Primary endpoints: Pharmacokinetic Parameters and Safety and Tolerability. Started May 2020; status: completed.
Beyond the preview
Go deeper on NCT04181437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04181437.